By Celgene | January 22, 2018

Celgene Corporation to Acquire Juno Therapeutics, Inc.

By Celgene | October 3, 2017

Nimbus, Celgene Strike Strategic Alliance to Develop Programs for Autoimmune Disorder Patients

By Celgene | September 1, 2017

Celgene to Expand Strategic Collaboration Scope with FORMA Therapeutics

By Celgene | June 19, 2017

EULAR 2017: Celgene Presents Mid-Stage Results for Novel Lupus Compound

By Celgene | May 22, 2017

Celgene Reports Positive Results for Phase 3 Study of Ozanimod